This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PANCREAS_ADENO_EXALLC for full statistics.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
C25
Cancer registry: Morphology ICD-O-3
8140
Cancer registry: Behaviour codes
3
1 out of 7 registries used, show all original rules.
638
Check minimum number of events None
638
Include endpoints None
638
Remove individuals based on genotype QC
620
C3_PANCREAS_ADENO
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma of pancreas
based on the number of shared cases.
Broader endpoints:
- Adenocarcinoma of pancreas (controls excluding all cancers)
- Adenocarcinoma and ductal carcinoma of pancreas (controls excluding all cancers)
- Adenocarcinoma and ductal carcinoma of pancreas
- Malignant neoplasm of pancreas (controls excluding all cancers)
- Malignant neoplasm of pancreas
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 620 | 236 | 384 |
| Unadjusted prevalence (%) | 0.15 | 0.10 | 0.21 |
| Mean age at first event (years) | 68.69 | 67.84 | 69.21 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_PANCREAS_ADENO – Adenocarcinoma of pancreas
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Adenocarcinoma of pancreas
↥Endpoint not on priority list, no data to show.